Global Rosuvastatin Market Research Report 2021

Global Rosuvastatin Market Research Report 2021

  • QYResearch
  • January 2021
  • Pharmaceutical
  • 118 pages

Report Description

1
1
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Purity 98.0%
Purity 99.0%
Other

Segment by Application
Tablet
Capsule
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences

Have query on this report?

Make an Enquiry
1 Rosuvastatin Market Overview
1.1 Product Overview and Scope of Rosuvastatin
1.2 Rosuvastatin Segment by Type
1.2.1 Global Rosuvastatin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Purity 98.0%
List of Tables
Table 1. Global Rosuvastatin Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Rosuvastatin Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Rosuvastatin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Rosuvastatin Covered in This Study
Table 5. Global Rosuvastatin Sales (K MT) of Key Manufacturers (2016-2021)

Success Stories

Our Clients